Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 8.76
(0.0%)
CNY 8.76
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 652.95 Million CNY | 24.23% |
| 2022 | 525.62 Million CNY | 99.21% |
| 2021 | 263.85 Million CNY | 137.73% |
| 2020 | 110.99 Million CNY | -4.89% |
| 2019 | 116.7 Million CNY | -2.26% |
| 2018 | 119.4 Million CNY | 144.67% |
| 2017 | 48.8 Million CNY | 211.74% |
| 2016 | 15.65 Million CNY | -6.05% |
| 2015 | 16.66 Million CNY | 20.69% |
| 2014 | 13.8 Million CNY | 0.34% |
| 2013 | 13.75 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 606.37 Million CNY | 7.08% |
| 2024 Q3 | 629.94 Million CNY | 3.89% |
| 2024 Q1 | 665.07 Million CNY | -2.13% |
| 2023 Q3 | 717.68 Million CNY | 4.31% |
| 2023 Q4 | 652.95 Million CNY | -9.02% |
| 2023 FY | 652.95 Million CNY | 24.23% |
| 2023 Q1 | 636.47 Million CNY | 21.09% |
| 2023 Q2 | 688.02 Million CNY | 8.1% |
| 2022 Q4 | 525.62 Million CNY | 39.96% |
| 2022 Q3 | 375.53 Million CNY | 2.95% |
| 2022 Q2 | 364.77 Million CNY | 3.27% |
| 2022 Q1 | 353.23 Million CNY | 33.87% |
| 2022 FY | 525.62 Million CNY | 99.21% |
| 2021 Q1 | 261.27 Million CNY | 135.4% |
| 2021 Q2 | 280.76 Million CNY | 7.46% |
| 2021 Q3 | 248.78 Million CNY | -11.39% |
| 2021 Q4 | 263.85 Million CNY | 6.06% |
| 2021 FY | 263.85 Million CNY | 137.73% |
| 2020 Q4 | 110.99 Million CNY | 4.22% |
| 2020 Q1 | 109.5 Million CNY | -6.17% |
| 2020 Q2 | 116.54 Million CNY | 6.44% |
| 2020 FY | 110.99 Million CNY | -4.89% |
| 2020 Q3 | 106.5 Million CNY | -8.62% |
| 2019 Q4 | 116.7 Million CNY | -14.51% |
| 2019 FY | 116.7 Million CNY | -2.26% |
| 2019 Q3 | 136.5 Million CNY | 24.49% |
| 2019 Q2 | 109.65 Million CNY | -4.15% |
| 2019 Q1 | 114.4 Million CNY | -4.19% |
| 2018 FY | 119.4 Million CNY | 144.67% |
| 2018 Q1 | 48.19 Million CNY | -1.24% |
| 2018 Q2 | 48.8 Million CNY | 1.26% |
| 2018 Q3 | 137.7 Million CNY | 182.17% |
| 2018 Q4 | 119.4 Million CNY | -13.29% |
| 2017 Q1 | 15.53 Million CNY | -0.75% |
| 2017 Q2 | 76.18 Million CNY | 390.39% |
| 2017 FY | 48.8 Million CNY | 211.74% |
| 2017 Q4 | 48.8 Million CNY | -35.68% |
| 2017 Q3 | 75.86 Million CNY | -0.42% |
| 2016 Q4 | 15.65 Million CNY | 3.9% |
| 2016 Q3 | 15.06 Million CNY | 0.74% |
| 2016 Q2 | 14.95 Million CNY | 2.57% |
| 2016 Q1 | 14.58 Million CNY | -12.48% |
| 2016 FY | 15.65 Million CNY | -6.05% |
| 2015 Q3 | 14.36 Million CNY | 0.0% |
| 2015 Q4 | 16.66 Million CNY | 15.99% |
| 2015 FY | 16.66 Million CNY | 20.69% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 FY | 13.8 Million CNY | 0.34% |
| 2013 FY | 13.75 Million CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 175.94 Million CNY | -271.113% |
| Yixintang Pharmaceutical Group Co., Ltd. | 1.55 Billion CNY | 57.933% |
| ZJAMP Group Co., Ltd. | 390.5 Million CNY | -67.209% |
| Ji Yao Holding Group Co., Ltd. | 676.64 Million CNY | 3.5% |